A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008904/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the
prevention of COVID-19.
提供机构：
Vivli
创建时间：
2023-04-21
